comparemela.com

Latest Breaking News On - Portage biotech - Page 3 : comparemela.com

Portage previews possible closure as it hunts for options

Portage previews possible closure as it hunts for options
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United-states
American
American-society-of-clinical-oncology
Portage-biotech
Tarus-therapeutics
American-society
Clinical-oncology

Portage Biotech Completes Monetization of Intensity

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
British
American
Ian-walters
Company-board-of-directors
Trial-safety-committee
Owners-of-the-company
Company-annual-report-on-form
Linkedin
Nasdaq
American-society-of-clinical-oncology

Portage Biotech Reports Results for Fiscal Quarter Ended

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update Company focused on adenosine platform clinical development.

United-kingdom
United-states
American
British
Ian-walters
Portage-biotech-inc
Company-board-of-directors
Linkedin
Company-annual-report-on-form
Trial-safety-committee
Owners-of-the-company
Nasdaq

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

WESTPORT, Conn., Feb. 28, 2024 Portage Biotech Inc. , a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported.

United-kingdom
United-states
British
American
Ian-walters
Company-board-of-directors
Trial-safety-committee
Company-annual-report-on-form
Owners-of-the-company
Linkedin
Nasdaq
Globenewswire-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.